We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wearable Sensor Accurately Measures Biomarker Concentrations in Sweat Samples

By HospiMedica International staff writers
Posted on 09 Jan 2024

Skin-applied sensors are emerging as a non-intrusive, affordable method for detecting vital biomarkers in sweat, aiding clinicians in making prompt and precise diagnoses. More...

However, until now, these sensors could only identify the presence of biomarkers and struggled with accurately detecting their concentrations due to the sporadic and unpredictable nature of sweat production. To address this challenge, a team of scientists has introduced a sensor that precisely measures biomarker concentrations in sweat samples.

The research team from Penn State (University Park, PA, USA) designed a dual-channel sensor for capturing sweat. One channel is tasked with measuring the biomarker level, while the other assesses the sweat volume. This sensor employs a dye that reacts to the presence of the biomarker and produces a visible indication, allowing for a simple, equipment-free reading. This feature makes the sensor particularly beneficial in remote settings where advanced technological resources may be scarce. Detecting the concentration of a biomarker is critical for accurate diagnostics. For instance, the team has proposed their sensor's application in diagnosing conditions like cystic fibrosis, typically characterized by elevated chloride levels in the patient.

“The typical course of action to diagnose cystic fibrosis is to induce a local sweat through exercise, but with our sensor, we can detect the chloride concentration in sweat without requiring the patient to exercise, since we can use passive heat-induced sweating with our wearable form of the testing setup,” said Huanyu “Larry” Cheng, the James L. Henderson, Jr. Memorial Associate Professor of Engineering Science and Mechanics at Penn State.

Related Links:
Penn State


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.